NCT07160621Recruiting
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 3 Sept 2026
Brief summary (registry, in English)
The purpose of the study is to determine if an adapted mobile cognitive behavioral therapy (CBT) app (WebMAP Onc) is more effective than standard pain education in reducing chronic pain and improving daily functioning in adolescent survivors of pediatric cancer. This randomized study led by St. Jude Children's Research Hospital will involve 228 participants (114 adolescent survivors and 114 caregivers) across four U.S. hospitals. Outcomes include pain reduction, improved function, and the role of social determinants of health. Assessments occur at baseline, post-treatment, and 3-month follow-up.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- First submitted
- 29 Aug 2025
- Start date
- 5 Sept 2025
- Primary completion date
- Jan 2028
- Lead sponsor
- St. Jude Children's Research Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT07160621
What you commit to
- Study type: Interventional
- Planned participants: 116
- From 5 Sept 2025 to the primary completion date, Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Adolescent Participants
- Serious comorbid psychiatric condition
- Current substance abuse as determined by the Substance Use Screening Questionnaire
- History of development delay or significant cognitive impairment
- Note: A participant who completed the feasibility study (ADAPTED) cannot participate in the subsequent clinical trial (ADAPTED2)
Other
- Parent/Caregiver Participants
- Not fluent in English or Spanish
- Unable to provide consent for own participation or for the participation of the adolescent participant
Who the study is looking for
- Adolescent Participants
- 10-17-year-old survivors of childhood cancer or those who received cancer directed therapies (e.g., Langerhan's Histiocytosis)
- At least one-year post treatment completion
- Pain present for 3 months or longer
- Pain interfering with at least one area of daily functioning
- Parent/Caregiver Participants
- ≥ 18 years of age
- Legally authorized to provide informed consent for the adolescent participant
Age in the registry: 10 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St. Jude Children's Research Hospital Coordinator of this site? Confirm its status | Memphis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.